The Impact of Genomic Changes on Treatment of Lung Cancer

Yazar: Cardarella, Stephanie, Johnson, Bruce E.
Baskı/Yayın Bilgisi 2013

Race, Poverty, and Initial Implementation of Precision Medicine for Lung Cancer

Yazar: Kehl, Kenneth L, Lathan, Christopher S, Johnson, Bruce E, Schrag, Deborah
Yayımlandı J Natl Cancer Inst (2018)

State of the Art: Response Assessment in Lung Cancer in the Era of Genomic Medicine

Yazar: Nishino, Mizuki, Hatabu, Hiroto, Johnson, Bruce E., McLoud, Theresa C.
Yayımlandı Radiology (2014)

Parity and Risk of Lung Cancer in Women

Yazar: Paulus, Jessica K., Asomaning, Kofi, Kraft, Peter, Johnson, Bruce E., Lin, Xihong, Christiani, David C.
Baskı/Yayın Bilgisi 2010

Haplotypes of Estrogen Receptor Beta and risk of Non-small cell lung cancer in women

Yazar: Paulus, Jessica K., Zhou, Wei, Kraft, Peter, Johnson, Bruce E., Lin, Xihong, Christiani, David C.
Baskı/Yayın Bilgisi 2010

Factors associated with smoking abstinence among smokers and recent-quitters with lung and head and neck cancer

Yazar: Cooley, Mary E., Wang, Qian, Johnson, Bruce E., Catalano, Paul, Haddad, Robert I., Bueno, Raphael, Emmons, Karen M.
Baskı/Yayın Bilgisi 2011

Imaging of Lung Cancer in the Era of Molecular Medicine

Yazar: Nishino, Mizuki, Jackman, David M., Hatabu, Hiroto, Jänne, Pasi A., Johnson, Bruce E., Van den Abbeele, Annick D.
Baskı/Yayın Bilgisi 2011

Automated image analysis tool for tumor volume growth rate to guide precision cancer therapy: EGFR-mutant non-small-cell lung cancer as a paradigm

Yazar: Nishino, Mizuki, Wakai, Satoshi, Hida, Tomoyuki, Dahlberg, Suzanne E., Ozaki, Masahiro, Hatabu, Hiroto, Tachizaki, Hisashi, Johnson, Bruce E.
Yayımlandı Eur J Radiol (2018)

Performance of a Machine Learning Algorithm Using Electronic Health Record Data to Identify and Estimate Survival in a Longitudinal Cohort of Patients With Lung Cancer

Yazar: Yuan, Qianyu, Cai, Tianrun, Hong, Chuan, Du, Mulong, Johnson, Bruce E., Lanuti, Michael, Cai, Tianxi, Christiani, David C.
Yayımlandı JAMA Netw Open (2021)

Development of Central Nervous System Metastases in Patients with Advanced Non-Small Cell Lung Cancer and Somatic EGFR Mutations Treated with Gefitinib or Erlotinib

Yazar: Heon, Stephanie, Yeap, Beow Y., Britt, Gregory J., Costa, Daniel B., Rabin, Michael S., Jackman, David M., Johnson, Bruce E.
Baskı/Yayın Bilgisi 2010

Unsuspected pulmonary embolism in lung cancer patients: Comparison of clinical characteristics and outcome with suspected pulmonary embolism

Yazar: Shinagare, Atul B., Okajima, Yuka, Oxnard, Geoffrey R., DiPiro, Pamela J., Johnson, Bruce E., Hatabu, Hiroto, Nishino, Mizuki
Baskı/Yayın Bilgisi 2012

Volumetric tumor response and progression in EGFR-mutant NSCLC patients treated with erlotinib or gefitinib

Yazar: Nishino, Mizuki, Dahlberg, Suzanne E., Fulton, Linnea E., Digumarthy, Subba R., Hatabu, Hiroto, Johnson, Bruce E., Sequist, Lecia V.
Yayımlandı Acad Radiol (2016)

Interstitial lung abnormality in stage IV non-small cell lung cancer: A validation study for the association with poor clinical outcome

Yazar: Araki, Tetsuro, Dahlberg, Suzanne E., Hida, Tomoyuki, Lydon, Christine A., Rabin, Michael S., Hatabu, Hiroto, Johnson, Bruce E., Nishino, Mizuki
Yayımlandı Eur J Radiol Open (2019)

M1b Disease in the 8th Edition of TNM Staging of Lung Cancer: Pattern of Single Extrathoracic Metastasis and Clinical Outcome

Yazar: Park, Hyesun, Dahlberg, Suzanne E., Lydon, Christine A., Araki, Tetsuro, Hatabu, Hiroto, Rabin, Michael S., Johnson, Bruce E., Nishino, Mizuki
Yayımlandı Oncologist (2019)

Patient report of receipt and interest in smoking cessation interventions after a diagnosis of cancer

Yazar: Cooley, Mary E., Emmons, Karen M., Haddad, Robert, Wang, Qian, Posner, Marshall, Bueno, Raphael, Cohen, Tiffany-Jen, Johnson, Bruce E.
Baskı/Yayın Bilgisi 2011

Tumoral cavitation in patients with non-small-cell lung cancer treated with antiangiogenic therapy using bevacizumab

Yazar: Nishino, Mizuki, Cryer, Sarah K., Okajima, Yuka, Sholl, Lynette M., Hatabu, Hiroto, Rabin, Michael S., Jackman, David M., Johnson, Bruce E.
Baskı/Yayın Bilgisi 2012

Tumor Volume Decrease at 8 weeks is Associated with Longer Survival in EGFR-mutant Advanced Non-Small-Cell Lung Cancer Patients treated with EGFR Tyrosine Kinase Inhibitor

Yazar: Nishino, Mizuki, Dahlberg, Suzanne E., Cardarella, Stephanie, Jackman, David M., Rabin, Michael S., Hatabu, Hiroto, Jänne, Pasi A., Johnson, Bruce E.
Baskı/Yayın Bilgisi 2013

RECIST 1.1 in NSCLC Patients With EGFR Mutations Treated With EGFR Tyrosine Kinase Inhibitors: Comparison With RECIST 1.0

Yazar: Nishino, Mizuki, Cardarella, Stephanie, Jackman, David M., Ramaiya, Nikhil H., Rabin, Michael S., Hatabu, Hiroto, Jänne, Pasi A., Johnson, Bruce E.
Baskı/Yayın Bilgisi 2013

Five-year survival in EGFR-mutant metastatic lung adenocarcinoma treated with EGFR-TKIs

Yazar: Lin, Jessica J., Cardarella, Stephanie, Lydon, Christine A., Dahlberg, Suzanne E., Jackman, David M., Jänne, Pasi A., Johnson, Bruce E.
Yayımlandı J Thorac Oncol (2015)

Tumor volume dynamics and tumor growth rate in ALK-rearranged advanced non-small-cell lung cancer treated with crizotinib

Yazar: Nishino, Mizuki, Hida, Tomoyuki, Kravets, Sasha, Dahlberg, Suzanne E., Lydon, Christine A., Hatabu, Hiroto, Johnson, Bruce E., Awad, Mark M.
Yayımlandı Eur J Radiol Open (2020)